SGRY (STOCKS)
Surgery Partners, Inc. Common Stock
$15.130000
-0.180000 (-1.18%)
Prev close: $15.310000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Hospital/Nursing Management
- CEO
- J. Eric Evans
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,980.13M
- Employees
- 15,000
- P/E (TTM)
- -25.73
- P/B (TTM)
- 1.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.03 | $-0.12 | +0.0890 | +74.79% |
|
Dec 2025 (Q4)
|
$0.12 | $0.31 | -0.1860 | -60.78% |
|
Sep 2025 (Q3)
|
$0.13 | $0.17 | -0.0389 | -23.03% |
|
Jun 2025 (Q2)
|
$0.17 | $0.14 | +0.0331 | +24.18% |
Financial Statements
| Revenues | $3.34B |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $2.95B |
| Operating Expenses | $2.95B |
| Depreciation and Amortization | $178.20M |
| Other Operating Expenses | $2.77B |
| Operating Income/Loss | $393.40M |
| Income/Loss Before Equity Method Investments | $3.32B |
| Income/Loss From Continuing Operations After Tax | $97.10M |
| Income/Loss From Continuing Operations Before Tax | $3.34B |
| Income/Loss From Equity Method Investments | $21.40M |
| Income Tax Expense/Benefit | $16.80M |
| Income Tax Expense/Benefit, Deferred | $15.70M |
| Net Income/Loss | $97.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $173.20M |
| Net Income/Loss Attributable To Parent | -$76.10M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $12.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$76.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.59 |
| Diluted Earnings Per Share | -$0.59 |
| Basic Average Shares | 382,830,000 |
| Diluted Average Shares | 382,830,000 |
| Assets | $8.04B |
| Current Assets | $1.08B |
| Inventory | $100.50M |
| Prepaid Expenses | $38.80M |
| Other Current Assets | $943.20M |
| Noncurrent Assets | $6.96B |
| Liabilities | $4.94B |
| Current Liabilities | $581.70M |
| Accounts Payable | $168.60M |
| Wages | $77.10M |
| Other Current Liabilities | $336.00M |
| Noncurrent Liabilities | $4.36B |
| Redeemable Noncontrolling Interest | $383.40M |
| Equity | $3.10B |
| Equity Attributable To Noncontrolling Interest | $1.41B |
| Equity Attributable To Parent | $1.69B |
| Temporary Equity | $383.40M |
| Liabilities And Equity | $8.04B |
| Net Cash Flow From Operating Activities | $280.00M |
| Net Cash Flow From Operating Activities, Continuing | $280.00M |
| Net Cash Flow From Investing Activities | -$183.60M |
| Net Cash Flow From Investing Activities, Continuing | -$183.60M |
| Net Cash Flow From Financing Activities | -$143.40M |
| Net Cash Flow From Financing Activities, Continuing | -$143.40M |
| Net Cash Flow | -$47.00M |
| Net Cash Flow, Continuing | -$47.00M |
| Comprehensive Income/Loss | $98.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $173.20M |
| Comprehensive Income/Loss Attributable To Parent | -$74.80M |
| Other Comprehensive Income/Loss | $1.30M |